AQR Capital Management’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Buy |
252,142
+87,354
| +53% | +$394K | ﹤0.01% | 2122 |
|
|
2025
Q1 | $730K | Buy |
164,788
+147,788
| +869% | +$655K | ﹤0.01% | 2214 |
|
|
2024
Q4 | $133K | Sell |
17,000
-10,247
| -38% | -$80.2K | ﹤0.01% | 2734 |
|
|
2024
Q3 | $358K | Buy |
27,247
+5,321
| +24% | +$70K | ﹤0.01% | 2314 |
|
|
2024
Q2 | $265K | Sell |
21,926
-15,915
| -42% | -$192K | ﹤0.01% | 2321 |
|
|
2024
Q1 | $615K | Buy |
+37,841
| New | +$615K | ﹤0.01% | 1881 |
|
|
2023
Q4 | – | Sell |
-245,482
| Closed | -$1.34M | – | 2459 |
|
|
2023
Q3 | $1.34M | Buy |
245,482
+45,982
| +23% | +$251K | ﹤0.01% | 1490 |
|
|
2023
Q2 | $1.35M | Sell |
199,500
-279,793
| -58% | -$1.9M | ﹤0.01% | 1433 |
|
|
2023
Q1 | $2.4M | Sell |
479,293
-877
| -0.2% | -$4.39K | 0.01% | 1174 |
|
|
2022
Q4 | $2.34M | Buy |
+480,170
| New | +$2.34M | 0.01% | 1194 |
|